Brind.

Analysts at Cantor Fitzgerald maintained an Overweight rating on Teradyne, citing strong AI growth prospects for the company.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Teradyne Cantor Fitzgerald

Keep exploring

The entities involved

Teradyne
company
- UBS analysts project upside for Teradyne, which is involved in the testing and supply chain of companies like Nvidia.Thu 23:36
Cantor Fitzgerald
American financial services company
- Avalo Therapeutics received multiple rating changes and analyst coverage from firms including Cantor Fitzgerald, Bank of America, and Weiss Ratings.14:08
- Cantor Fitzgerald reiterated its 'overweight' rating on Oracle stock on June 11, 2026.11:02

Coverage

Newest first; wire copies grouped

Jul 31Motley FoolWhy Teradyne Stock Soared 18.9% Today The company reported its Q2 earnings, beating most of Wall Street's targets. Guidance for Q3 EPS missed forecasts, but revenue projections suggest a second-half